Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 7/2013

01-07-2013 | Letter to the Editor

Successful treatment of secondary NK/T-cell lymphoma of the testis

Authors: Takashi Kobayashi, Akira Hangaishi, Go Yamamoto, Akihito Shinohara, Teppei Morikawa, Yutaka Takazawa, Satoshi Ota, Yoichi Imai, Fumihiko Nakamura, Mineo Kurokawa

Published in: Annals of Hematology | Issue 7/2013

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Liang R (2009) Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type. Br J Haematol 147(1):13–21PubMedCrossRef
2.
Aozasa K, Takakuwa T, Hongyo T, Yang WI (2008) Nasal NK/T-cell lymphoma: epidemiology and pathogenesis. Int J Hematol 87(2):110–117PubMedCrossRef
3.
Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, Ishizawa K, Maseki N, Itoh K, Usui N, Wasada I, Kinoshita T, Ohshima K, Matsuno Y, Terauchi T, Nawano S, Ishikura S, Kagami Y, Hotta T, Oshimi K (2009) Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol 27(33):5594–5600PubMedCrossRef
4.
Chan JK, Tsang WY, Lau WH, Cheung MM, Ng WF, Yuen WC, Ng CS (1996) Aggressive T/natural killer cell lymphoma presenting as testicular tumor. Cancer 77(6):1198–1205PubMedCrossRef
5.
Liang DN, Yang ZR, Wang WY, Zhao S, Yang QP, Tang Y, Bi CF, Liu WP (2012) Extranodal nasal type natural killer/T-cell lymphoma of testis: report of seven cases with review of literature. Leuk Lymphoma 53(6):1117–1123PubMedCrossRef
6.
Matsuda M, Iwanaga T, Hashimoto S, Uesugi T, Itagaki N (2009) Primary Epstein–Barr virus-negative nasal-type natural killer/T cell lymphoma of the testis. Leuk Res 33(8):e119–120PubMedCrossRef
7.
Kim YB, Chang SK, Yang WI, Hahn JS, Koom WS, Shim SJ, Park W, Lee KK, Suh CO, Kim GE (2003) Primary NK/T cell lymphoma of the testis. A case report and review of the literature. Acta Haematol 109(2):95–100PubMedCrossRef
Metadata
Title
Successful treatment of secondary NK/T-cell lymphoma of the testis
Authors
Takashi Kobayashi
Akira Hangaishi
Go Yamamoto
Akihito Shinohara
Teppei Morikawa
Yutaka Takazawa
Satoshi Ota
Yoichi Imai
Fumihiko Nakamura
Mineo Kurokawa
Publication date
01-07-2013
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 7/2013
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-012-1657-1

Other articles of this Issue 7/2013

Annals of Hematology 7/2013 Go to the issue

Original Article

Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis

Letter to the Editor

Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab

Original Article

Comparison of 7-day azacitidine and 5-day decitabine for treating myelodysplastic syndrome

Original Article

Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials

Original Article

Superior vena cava syndrome and poor performance status at presentation affect survival in mediastinal T-lymphoblastic lymphoma—a single institute experience from India

Letter to the Editor

Topical evening primrose oil for reduction of bortezomib-induced skin reactions
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits